rc 3095 has been researched along with Colitis Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damin, DC; Heck, R; Kliemann, LM; Meurer, L; Roesler, R; Rosito, MA; Santos, FS; Schwartsmann, G | 1 |
1 other study(ies) available for rc 3095 and Colitis Gravis
| Article | Year |
|---|---|
Effects of the gastrin-releasing peptide antagonist RC-3095 in a rat model of ulcerative colitis.
Topics: Animals; Bombesin; Colitis, Ulcerative; Colon; Female; Gastrin-Releasing Peptide; Immunohistochemistry; Male; Peptide Fragments; Rats; Rats, Wistar | 2010 |